The HLA-C locus remains an enigma. The serological polymorphism is poorly defined, HLA-C molecules are expressed at the cell surface at about 10% the levels of HLA-A and -B, and their importance for antigen presentation to either CDS-bearing T cells or natural killer cells is undear. Our understanding of HLA-C polymorphism has also lagged behind that of HLA-A and -B. We have applied the polymerase chain reaction to the characterization of eDNA encoding HLA-C antigens. Combining the recent results with previously characterized HLA-C alleles gives a data base of 26 sequences, which was used to analyze the nature of HLA-C polymorphism and compare it to the variation seen in HLA-A and -B. The sequences form 10 families of alleles that correlate well with the patterns of serological crossreactivity, including the C blanks, and all major HLA-C allelic families appear to have been sampled. The families further divide into two groups of HLA-C alleles defined on the basis of linked substitutions in the 3' exons. In comparison with HLA-A and -B, HLA-C alleles are more closely related to each other, there being less variation in residues of the antigen recognition site and more variation at other positions. In particular, the helix of the (xl domain of HLA-C molecules is unusually conserved. Despite the reduced diversity in the antigen recognition site, it is evident that HLA-C genes have been the target of past selection for polymorphism. Within the antigen recognition site, it is the ol1 domain that is most diagnostic of HLA-C, whereas the o~2 domain is similar to that of HLA-B, the locus to which HLA-C is most closely related. In particular, conserved motifs in the or1 helix and the conserved glycine at the base of the B pocket (position 45) provide a combination of features that is uniquely found in HLA-C molecules. We hypothesize that these features restrict the peptides bound by HLA-C molecules and in this manner reduce the efficiency of HLA-C assembly and expression at the cell surface. The overall picture of HLA-C polymorphism obtained from this sampling of HLA-C alleles is unlikely to change as further alleles are characterized.
H
LA-A and -B heavy chains are polymorphic glycoproteins that associate noncovalently with 132-microglobulin (B~-m).l The function of these molecules is to bind and present antigenic peptides to CTL (reviewed in reference 1). Although many examples of antigenic peptides presented in an aUele-specific manner by HLA-A or -B molecules have been described, the role of the homologous HLA-C molecules in the immune response is still poorly understood. Due to their weak immunogenicity and the lack of specific reagents, serological typing of the products of the HLA-C locus has been persistently difficuh, and some 20% of HLA-C alleles type blank in most populations (2) (3) (4) (5) . Furthermore, HLA-C antigens are expressed on cell surfaces to a much lesser extent ('~10%) than either HLA-A or -B (6) (7) (8) , and exhibit 1 Abbreviation used in this paper: 13z-m, B2-microglobulin. heterogeneity in their carbohydrate moiety (8) . In addition, analysis of HLA-C heavy chains by IEF reveals an unexplained heterogeneity that is not due to sialic acid (7, 9) . HLA-C molecules are also distinguished by inefficient assembly with /~2-m and slower rate of exocytosis, which presumably contribute to the lower cell surface expression (10) . These differences are not the result of lower levels of transcription or translation as HLA-C heavy chains are synthesized in amounts similar to HLA-A and HLA-B heavy chains (10, 11) .
Analysis of alloreactive responses has shown HLA-C molecules can be recognized by the receptors of human CTL, both in in vitro culture (12) (13) (14) and in allograft rejection (15) . Furthermore, EBV-specific cytotoxic T cells restricted by HLA-C have been described (16) , and a peptide derived from the gag protein of HIV-1 was shown recently to be presented by HLA-Cw3 (17) . The functional capacity of the Cw3 molecule has also been examined in transgenic mice, and examples of mouse CTL recognizing both viral peptides presented by Cw3, and Cw3 as an alloantigen, were found (18) . These results demonstrate that HLA-C molecules can participate in the immune response, a concept also supported by the association of HLA-C antigens with susceptibility to disease (19) (20) (21) (22) (23) . Giissow et al. (7) , however, have suggested that "HLA-C may be dispensable for proper functioning of the immune system" and concerns as to the significance of the contribution of HLA-C to protective immunity compared with HLA-A and B remain (24, 25) .
The feature that dearly distinguishes HLA-C from HLA-A and -B is its low cell surface expression, and in this regard, HLA-C is similar to the H-2L a molecule (26) , which is "expressed on the cell surface at levels three to four times lower than D a or K d'' (27) . In the case of H-2L d, reduced expression correlates with slower transport to the cell surface, and weaker association with 32-m (27) . Analysis of chimeric molecules formed by exon shuftting of the H-2D d and H-2L a genes showed the sequence of the o~1 domain determined the level of cell surface expression (28) . Furthermore, expression of H-2L d at the surface can be increased fourfold by feeding cells with an appropriate peptide ligand (29) . That all HLA-C alleles appear to give low expression at the cell surface (5, 10) suggests HLA-C heavy chains share sequence motifs that confer this property. In this paper, we analyze the sequences of HLA-C alleles to identify such features.
Molecular analysis of HLA-C polymorphism has been impeded by the difficulties in serological HLA-C typing and in purifying HLA-C proteins. Similarly, the isolation and molecular characterization of HLA-C alleles has lagged behind that of HLA-A and -B alleles. Application of the PCR to the specific cloning of HLA-C alleles circumvents these problems (30, 31) and has facilitated comparison here of 26 HLA-C alleles. This analysis has permitted determination of the nature of HLA-C polymorphism, its comparison with that of HLA-A and -B, and the identification of features that might determine low cell surface expression.
Materials and Methods
The isolation and characterization of HLA-C cDNA from human B cell lines was essentially as described by Ennis et al. (30) , except that the 3' oligonucleotide primer used in amplification by the PCR was derived from a region of the 3' untranslated region that contained HLA-C-specific substitutions. The sequences of the two primers used in amplification were HLA-SP2: 5' GCC CGT CGA CGG ACT CAG AAT CTC CCC AGA CGC CGA G 3' (5' primer), and HLA-3pC: 5' CCG CAA GCT TTC GC~ GAG GGA ACA CAG GTC AGT GTG GGG AC 3' (3' primer) (31) . This strategy, which yields the entire coding region, has been used to isolate alleles encoding the previously uncharacterized Cw4 and Cw8 antigens and novel subtypes of Cwl and Cw3.
Previously published HLA-C sequences used in this analysis were Cw*0101, Cw*0201 (7); Cw*0301 (32); Cw*0102, Cw*0302 (33); Cw*02021 (34); Cw*02022 (35); BeWo C.1 (36); C1.9 and C1.10 (37); CW6P, Cw*0701 (38) ; Cw*0501 and Cw'1301 (3); Cw*0601 (39); Cw*0702 (40) ; Cw*0801 and Cw*0802 (31); Cw*0803 (41); Cw'1201 (42); Cw'1202 and Cw'1401 (4); HLA-4 (43); and C*X (44) . World Health Organization nomenclature for the alleles and their previous designations are described in references 45 and 46. In comparison with the other 25 HLA-C alleles, Cw*0301 (the first C allele sequenced [32] ) has an unusually high number of unique substitutions. For HLA-A and -B, a number of such substitutions have proved to be the result of errors or artifacts introduced in cloning and sequencing. Supporting this contention for Cw*0301 are the results we obtained from sequencing Cw3 from AP, a cell line of Korean origin (33) . This allele (Cw*0302) differs from Cw*0301 by 16 nucleotide substitutions in the 1,101 base pairs of the coding region, which produce a 10-amino acid substitution (six in the c~1 domain and four in the c~2 domain). At all six of the substitutions in the c~1 domain, Cw*0301 has a unique residue, whereas Cw*0302 is identical to the consensus. Four of the positions occur in two pairs (40,41 and 54,55) , which could be due to localized misordering of the sequence; one of these substitutions (55) would destroy the conserved salt bridge that links the st and c~2 helices; a fifth substitution (69) places a proline in the c~1 helix providing additional reason for concern. Within the c~2 domain, the published Cw*0301 sequence placed a unique glycine at 181, which was subsequently corrected to the consensus residue arginine (47) . Of the remaining three positions of difference, 95 and 116 are consistent with the general pattern of diversity of class I molecules and are those most likely to represent real differences. Asparagane 137 is unique to Cw*0301. The nucleotides at these positions in both Cw3 sequences are seen in other class I HLA sequences and two of the positions point into the peptide binding groove. Thus, in our analyses, the Cw*0301 sequence has not always been included.
Results
The sequences of 26 alleles of the HLA-C locus have now been determined. This base of data is the result of independent research from 15 laboratories (2, 3, 6, 7, 31-44, 48, 49) , and in some instances, clones encoding HLA-C alleles have emerged from the study of immunological phenomena not immediately related to class I HLA molecules (36, 49) . Determination of serologicaUy well-characterized HLA-C alleles now permits identification of these sequences of unknown HLA-C alleles.
HLA-Cw4 Is Identical to the PL208 Clone Isolated on the Basis of Serological Crossreactivity with gp120. The Cw4-encoding allele Cw*0401 was characterized from the mutant B cell line C1R of Caucasian origin, which expresses Cw4 as the only serologicaUy detected class I antigen (48) . Subsequently, we and Watkins et al. (41, 44) cloned the identical Cw4 allele from cell lines derived from Native South Americans and poorly characterized for HLA-C alleles. Thus, the Cw*0401 allele is widely dispersed in human populations, and in the C1R mutant, the Cw4 gene has not undergone mutation.
Beretta et al. (49) identified a mAb (M38) with specificity for both the gp120 of HIV-1 and a surface protein of activated lymphocytes and monocytes. This group subsequently cloned a cDNA encoding the M38 antigen from a library made from PHA-activated lymphocytes of unknown HLA type (50) . This cDNA "revealed a high degree of homology with the class I MHC gene family" The sequence being "not identical to any of the already sequenced alleles" but having maximal homology to alleles of the HLA-C locus. We discovered the sequence of this PL208 clone to be identical to Cw*0401. Grassi et al. (50) (36) , which was obtained from the "HLA-A,B,Cnegative" choriocarcinoma cell line BeWo, is now seen to be most closely related to Cw*0401. Amino acid substitutions at five positions, 49, 50, and 68 in the c~1 domain and 155 in the o~2 domain, and 340 in the cytoplasmic domain, distinguish the two sequences (Fig. 1) . Thus, BeWo C.1 appears to be a subtype of Cw4. Ellis et al. (36) found it "impossible to obtain a tissue type for BeWo ceils" suggesting the amino acid differences between the subtypes may have an affect on serological determinants. Ahematively, the c~6c~ ties in typing this nonlymphoid cell may be due to low cell surface density of the class I molecules.
HLA-Cw8 and Cw3 Sequences. We have cloned alleles corresponding to the Cw8 antigen from cell lines of Caucasian and Native American origin, and partial sequences of two alleles were previously reported (33) in an analysis of the serological properties of the HLA-B46 molecule. Three subtypes have now been defined, which differ by one to four amino acid substitutions 9 The Caucasian subtype of Cw8 (Cw*0802) differs by just a single amino acid from the HLA-C sequence reported by Bronson et al. (51) , and which was derived from a yeast artificial chromosome (YAC) library made from the CGM1 cell line. The Cw*0801 subtype, which was isolated from a Native North American, is identical to the sequence that we erroneously thought corresponded to the Cwll antigen (33, 52) . The HLA-Cwll antigen is now known not to define a unique allele but an epitope shared by B46 and Cwl molecules. The third subtype Cw*0803 was obtained from a Native South American of the Kaingang tribe (41) .
Two Groups of HLA-C Sequences. Comparison of the 26 HLA-C sequences reveals a group of three that stand out from the rest: Cw'0701, HLA-4, and Cw*0702 (previously called JY328 [40] ). The HLA-4 and Cw*0702 sequences were derived from serologically uncharacterized alleles (40, 43) , but their striking sequence similarity to HLA-Cw*0701 shows they comprise a group of Cw7 subtypes. Frequency histograms representing the distribution of nucleotide differences between pairs of HLA-C alleles dearly show the Cw7 sequences form a distinct group (Fig. 2) , and this can also be seen with a dendogram calculated using the unweighted pairgroup method using arithmetic averages (53) from the HLA-C sequences (Fig. 3) . Characteristic of the Cw7 group is a series of 16 nucleotide substitutions spread through exons 4-8, which produce 11 amino acid substitutions (Fig. 1) . These substitutions are common to Cw*0701, Cw*0702, and HLA-4, but are found in no other HLA-C sequences. An additional three nucleotide substitutions, of which two are coding changes, are unique to two of the three sequences. The independent determination of the JY328, HLA-4, and Cw7 sequences in different laboratories (38, 40, 43) gives confidence to the validity of this unique set of linked substitutions; furthermore, they have also been found in gorilla homologues of HLA-C (54). HLA-Cw7 is the most common HLA-C antigen in many human populations (2), having a frequency of '~40% in Caucasians, for example (22) . Thus, the representation at the population level of the unusual Cw7 sequence is much greater than appreciated from simple comparisons in which alleles are given equal weight irrespective of frequency (55) .
Locus-specific substitutions are found in the 3' exons and the 3' untranslated regions of class I HLA genes (43, 52, 56, 57) , suggesting the Cw7 subtypes may represent a locus distinct from that encoding the other HLA-C antigens. Indeed, an RFLP analysis by Duceman et al. (58) suggested that was the case for the JY328 gene. A more recent study, however, favors the interpretation that all HLA-C antigens are encoded by the alleles of a single locus (59) . In that case the linked substitutions in the Cw7 alleles may have originated from another locus and been introduced into a C allele by gene conversion.
Correlation of Structure and Serology. For the most part, the structural relationships defined by the dendogram (Fig.  3) are consistent with the patterns of HLA-C serological crossreactivity. All alldes serologically typed as the same antigen group together, for example, the various subtypes of the serologically defined antigens. Similarly, the Cw5 and Cw8 antigens that are serologically crossreactive (60) are found to be most closely related in sequence. An exception to such correlations is provided by the Cw4 and Cw6 antigens, which are serologically crossreactive (61) Approximately 20% of HLAoC alleles cannot be serologically typed (2) , and structures for a number of these blank alleles have been determined (3, 4, 42 
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Zemmour and Patham (62) was calculated for 24 HLA-A, 24 HLA-B, and 24 HLA-C sequences. The variability at each position in a set of homologous sequences is defined as the number of different amino acids found at the position divided by the frequency of the most common residue. * Conserved position. parent is that eight positions that show high variability in either HLA-A or -B are conserved in all HLA-C sequences. These residues focus on the (~1 helix and result in this element of the antigen recognition site being highly conserved in HLA-C molecules. This property undoubtedly contributes to the difficulty in the serological definition of HLA-C alleles, as variation in the or1 helix produces many of the epitopes that distinguish HLA-A and -B molecules (63) . Crystallography has defined six specificity pockets within the binding groove that accommodate peptide side chains and terminal groups (64) (65) (66) (67) . Overall, the sequence motifs found in these pockets of HLA-C molecules are distinct from those in HLA-A and -B. The peptides bound by HLA-C are therefore expected to be distinct. Although exhibiting a small number of positions of high variability, there is at least one such position in each of the specificity pockets for HLA-C (Fig. 6) .
Analysis of the interaction between HLA-B27 and peptide shows the B pocket plays a critical "anchoring" role in binding the arginine at position 2, which is common to B27-binding peptides (68) (69) (70) . In particular, the negatively charged glutamic acid at position 45 at the base of the pocket forms an electrostatic interaction with the arginine side chain of the peptide. Contrasting with HLA-B molecules for which the B pocket is highly diversified, the B pocket of HLA-C molecules is conserved. Of significance is that residue 45 is a conserved glycine that may contribute little to peptide interaction. Thus, the anchoring role for the B pocket in HLA-B could be absent or attenuated in HLAoC.
In the extraceUular domains there are 12 positions at which HLA-C shows variability and where HLA-A and/or -B are conserved. None of these is in the antigen recognition site. Thus, no residues of the peptide binding groove are uniquely variable in HLA-C. In contrast, of 24 residues that are con . The size and charge differences between the glycine at this position in HLA-C and the arginine found in HLA-B could have an influence on the association with fl2-m. In HLA-A2, arginine 181 forms a salt bridge with aspartate 183 and this combination of residues is conserved in HLA-B. Substitution of glutamate for aspartate at 183 in HLA-C might perturb this salt bridge and the interaction between the oe2 and o~3 domains. Glutamate 268, which is located on the seventh B strand of the o~3 domain, is surrounded by two proline residues. In all HLA-A and -B heavy chains this glutamate is replaced by the oppositely charged lysine. In the vicinity is glutamate 264, which contacts threonine 182 in the HLA-A2 structure (67) . Within the cytoplasmic domains are four HLA-C-specific residues. These comprise cysteine 321, asparagine 328, glutamate 335, and isoleucine 338. Of these, cysteine 321 replaces a tyrosine in HLA-A and -B molecules that can be phosphorylated in vitro (76) . These substitutions could possibly affect interactions with cytoplasmic proteins or other membrane components.
Discussion
In comparison with HLA-A and -B, the HLA-C locus has been studied less and remains poorly understood. Here, we present the first extensive analysis of the polymorphism of HLA-C alleles. It reveals that the serological description of HLA-C antigens generally reflects the underlying structures of the alleles, which are variations on 10 basic motifs. Although some 20% of HLA-C alleles cannot be defined by serological HLA typing, these form two groups, suggesting the blank does not encompass a multitude of undiscovered alleles. Overall, there is good indication that the 26 alleles analyzed here are representative of the HLA-C alleles to be found in human populations and that few, if any, distinctive motifs remain to be found.
The hallmark of class I antigen-presenting molecules is their polymorphism, which crystallography has shown is concentrated in functional positions of the antigen recognition site. Pairs of HLA-C alleles show fewer differences than their HLA-A and -B homologues, and this property is reflected in a greater homogeneity of the antigen recognition site. Conservation of sequence in the oll helix and in the B pocket is particularly striking.
Despite similar levels of mRNA and heavy chain protein (10, 11, 74) , cell surface expression of HLA-C molecules is '~10% that of HLA-A and -B. This appears to be true for all HLA-C alleles, and one goal of our analysis was to identify features shared by HLA-C molecules that could account for this distinguishing property. Candidates are found in the c~1, a3, and cytoplasmic domains, but it is those of the o~1 domain that are most impressive. These residues largely overlap with the conserved residues of the o~i helix and the B pocket, raising the possibility that inefficient assembly and cell surface expression of HLA-C molecules is primarily a failure in the binding of peptides. This could be due to an intrinsic property of the antigen binding groove of HLA-C molecules, which have low affinity for the majority of peptides generated from endogenous proteins. The conserved features of the pockets formed by the c~1 domain could be instrumental in producing such binding properties. As a consequence, HLA-C may selectively bind a restricted set of peptides, perhaps those more commonly in the sequences of foreign, rather than self-proteins. Selectivity in the proteases that produce antigenic peptides or in the peptides delivered to the endoplasmic reticulum (ER) could act to restrict the supply of HLA-C binding peptides in the Elk. The routine molecule H-2L a exhibits inefficient cell surface expression, which can be enhanced by external provision of appropriate peptides (29) . It will be important to see if the same is true for HLA-C and if viral infection acts to increase HLA-C expression through this mechanism.
Low cell surface expression of HLA-C may not result from a deficiency in binding peptides but from interactions of the HLA-C heavy chain with other components that contribute to the assembly and transport of class I molecules. For example, if HLA-C were to have a weaker interaction with 32-m, or a stronger interaction with the heavy chain binding chaperonin (77) , than HLA-A or -B, then expression would be predicted to be reduced.
Previous analysis of class I HLA genes and pseudogenes has correlated function with polymorphism. Thus, the HLA-A and -B genes, which function in antigen presentation to T cells, are highly polymorphic, whereas the pseudogenes, HLA-H and J, are conserved (25, 78, 79) . HLA-C is intermediate in character both in level of expression and diversification. This property led to suggestions that HLA-C is less functional than HLA-A or -B, a dispensable or declining locus (7, 24, 25) . Alternatively, HLA-C could be a more recently formed locus that is still undergoing improvement.
From the evidence available it seems clear that HLA-C is not a defunct class I locus. HLA-C molecules bind peptides and interact with TCKs in a variety of experimental systems (12) (13) (14) (15) (16) (17) (18) . Moreover, HLA-C alleles are correlated with susceptibility to diseases believed to be autoimmune in nature (Psoriasis vulgaris for example) (21, 80) .
The low cell surface expression may represent an adaptation giving HLA-C molecules complementary functions to those of HLA-A and -B. For example, by not being saturated with endogenous peptides, HLA-C may be poised to present particular viral peptides. The low expression would be expected to influence thymic selection, and in this manner may enable distinctive sets of T cells (high affinity, perhaps) to be selected by HLA-C. In this regard, it is worth noting that residues of the oe3 domain important for CD8 interactions (81, 82) are preserved in HLA-C molecules, although a direct demonstration for the interaction between HLA-C molecules and CD8 has yet to be made.
Recent studies on NK cell specificity have implicated
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Zemmour and Parham HLA-C molecules in the negative regulation of allotypic NK clones (83) . In this regard, the unusual features of the C pocket of HLA-C are of particular interest, as HLA-A2 has been shown to poorly inhibit NK cells due to a unique histidine at position 74 in the C pocket (84) . Moreover, Asahina et al. (80) have shown that susceptibility to psoriasis correlates with the presence of alanine at position 73 in the C pocket of HLA-C molecules.
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